Use of a novel bone graft substitute in peri-articular bone tumours of the knee

Knee

Volumn 14, Issue 6, 2007, Pages 458-464

  Schindler, Oliver S ^a   Cannon, Stephen R ^b   Briggs, Timothy W R ^b   Blunn, Gordon W ^c  

^a Droitwich Knee Clinic   (United Kingdom)

^b ROYAL NATIONAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

ABC; Benign bone tumour; Bone graft; Bone substitute; Composite bone graft; Giant cell tumour; Peri articular fracture; Synthetic bone graft

Indexed keywords

CALCIUM SULFATE;

ADOLESCENT; ADULT; ANEURYSMAL BONE CYST; ARTICLE; BONE GRAFT; BONE PROSTHESIS; COMPOSITE GRAFT; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; GIANT CELL TUMOR; HUMAN; ILIAC CREST; KNEE DISEASE; MALE; MUSCULOSKELETAL TUMOR SOCIETY RATING SCORE; OSTEOLYSIS; OUTCOME ASSESSMENT; POROSITY; PRIORITY JOURNAL; SCHOOL CHILD; SCORING SYSTEM; TUMOR RECURRENCE;

ADULT; BONE CYSTS, ANEURYSMAL; BONE NEOPLASMS; BONE SUBSTITUTES; CALCIUM SULFATE; CHILD; DURAPATITE; FEMALE; FEMUR; FOLLOW-UP STUDIES; GIANT CELL TUMOR OF BONE; HUMANS; MALE; MIDDLE AGED; TIBIA; TREATMENT OUTCOME;

EID: 36249004949     PISSN: 09680160     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.knee.2007.07.001     Document Type: Article

References (83)

1. Capanna R., Sudanese A., Baldini N., and Campanacci M. Phenol as an adjuvant in the control of local recurrence of benign neoplasms of bone treated by curettage. J Orthop Traumatol 11 (1985) 381-388
2. Lane J.M. Liquid nitrogen as an adjunct. Chir Organi Mov 75 (1989) 198-203
3. Rock M. Adjuvant management of benign tumors: basic concepts of phenol and cement use. Chir Organi Mov 75 (1989) 195-198
4. Schiller C., Ritschl P., Windhager R., Kropej D., and Kotz R. Die Rezidivhäufigkeit phenolisierter und nicht phenolisierter Knochenhöhlen nach intraläsionären Resektionen nicht maligner Knochentumoren. Z Orthop ihre Grenzgeb 127 (1989) 398-401
5. Marcove R.C., Sheth D.S., Takemoto S., and Healey J.H. The treatment of aneurysmal bone cyst. Clin Orthop Relat Res 311 (1994) 157-163
6. Bitzan P., Windhager R., Lang S., Riechling B., and Kotz R. Die Rezidivhäufigkeit aneurysmatischer Knochenzysten nach chirurgischer Behandlung und adjuvanter Therapie mit Phenol. Z Orthop ihre Grenzgeb 133 (1995) 422-428
7. Malawer M.M., Bickels J., Meller I., Buch R.G., Henshaw R.M., and Kollender Y. Cryosurgery in the treatment of giant cell tumor. A long-term follow-up study. Clin Orthop Relat Res 359 (1999) 176-188
8. Cockin J. Autologous bone grafting complications at the donor site. J Bone Jt Surg Br Vol 53-B (1971) 153
9. Coventry M.B., and Tapper E.M. Pelvic instability: a consequence of removing iliac bone for grafting. J Bone Jt Surg Am Vol 54-A (1972) 83-102
10. Michanie E., Cosentino E., Baptista P., and Biagini R. Autoplastic grafting from the iliac wing: surgical technique, indications and complications. Chir Organi Mov 77 (1992) 281-288
11. Agerholmh J.C., and Goodfellow J.W. Simple bone cysts of the humerus treated by radical excision. J Bone Jt Surg Br Vol 47-B (1965) 714-717
12. Neer C.S., Francis K.C., Marcove R.C., Terz J., and Carbonara P.N. Treatment of unicameral bone cyst: a follow-up study of one hundred seventy-five cases. J Bone Jt Surg Am Vol 48-A (1966) 731-745
13. Younger E.M. Morbidity of bone graft donor sites. J Orthop Trauma 3 (1989) 192-195
14. Younger E.M., and Chapman M.W. Morbidity at bone graft donor sites. J Orthop Trauma 3 (1990) 192-195
15. Arrington E.D., Smith W.J., Chambers H.G., Bucknel A.L., and Davino N.A. Complications of iliac crest bone graft harvesting. Clin Orthop Relat Res 329 (1996) 300-309
16. Banwart J.C., Asher M.A., and Hassanein R.S. Iliac crest bone graft harvest donor site morbidity: a statistical evaluation. Spine 20 (1995) 1055-1060
17. Gitelis S. Current concepts of treatment of bone tumors: 1. Giant-cell tumor: staging and treatment. In: Schajovwicz F. (Ed). Tumors and tumorlike lesions of bone: pathology, radiology and treatment (1994), Springer-Verlag, New York 613-643
18. Pals S.D., and Wilkins R.M. Giant cell tumor of bone treated by curettage, cementation, and bone grafting. Orthopaedics 15 (1992) 703-708
19. O'Donnell R.J., Springfield D.S., Motwani H.K., Ready J.E., Gebhardt M.C., and Mankin H.J. Recurrence of giant cell tumors of the long bones after curettage and packing with cement. J Bone Jt Surg Am Vol 76-A (1994) 1827-1833
20. Komiya S., and Inoue A. Cementation in the treatment of giant cell tumor of bone. Arch Orthop Trauma Surg 112 (1993) 51-55
21. Persson B.M., and Wouters H.W. Curettage and acrylic cementation in surgery of giant cell tumors of bone. Clin Orthop Relat Res 120 (1976) 125-133
22. Persson B.M., Ekelund L., Lövedahl R., and Gunterberg B. Favourable results of arcrylic cementation for giant cell tumors. Acta Orthop Scand 55 (1984) 209-214
23. Damien C.J., Parsons J.R., Benedict J.J., and Weisman D.S. Investigation of a hydroxyapatite and calcium sulfate composite supplemented with an osteoinductive factor. J Biomed Mater Res 24 (1990) 639-654
24. Damien C.J., and Parsons J.R. Bone graft and bone graft substitutes: a review of current technology and applications. J Appl Biomater 2 (1991) 187-208
25. Burwell R.G. History of bone grafting and bone substitutes with special reference to osteogenic induction. In: Urist M.R., O'Connor B.T., and Burwell R.G. (Eds). Bone grafts, derivatives and substitutes (1994), Butterworth Heinemann, Oxford 3-102
26. Oehlecker F. Über Knochenplombe. Zentbl Chir 52 (1925) 993
27. Stachow. Versuch über Knochenplombierung bei höhlenförmigen Defekten des Knochens. Beitr Klin Chir 12 (1894) 389-408
28. Nielson A. Filling of sterile and infected bone cavities by means of plaster of Paris. Acta Chir Scand 91 (1944) 17-27
29. Häuptli O. Die Gipsplombe zur Auffüllung von fehlendem Knochengewebe. Schweiz Med Wochenschr 82 (1952) 161-168
30. Peltier L.F. The use of plaster of Paris to fill defects in bone. Clin Orthop Relat Res 21 (1961) 1-31
31. Peltier L.F., and Jones R.H. Treatment of unicameral bone cysts by curettage and packing with plaster-of-Paris pellets. J Bone Jt Surg Am Vol 60-A (1978) 820-822
32. Tarsoly E. Ausfüllung der Knochenhöhlen mit Eierschalen-Gips-Gemisch. Acta Chir Hung 4 (1963) 63-72
33. Kelly C.M., Wilkins R.M., Gitelis S., Hartjen C., Watson J.T., and Kim P.T. The use of a surgical grade calcium sulphate as a bone graft substitute. Results of a multicentre trial. Clin Orthop Relat Res 382 (2001) 42-50
34. Albee F.H., and Morrison H.F. Studies in bone growth: tricalcium phosphate as a stimulus to osteogenesis. Ann Surg 71 (1920) 32-39
35. Yamamoto T., Onga T., and Mizuno K. Use of hydroxyapatite to fill cavities after excision of benign bone tumours. Clinical results. J Bone Jt Surg 82-B (2000) 1117-1120
36. Gitelis S., Piasecki P., Turner T., Haggard W., Charters J., and Urban R. Use of calcium sulphate based bone graft substitute for benign bone lesions. Orthopedics 24 (2001) 162-166
37. Bucholz R.W. Nonallograft osteoconductive bone graft substitutes. Clin Orthop Relat Res 395 (2002) 44-52
38. Hirata M., Murata H., Takeshita H., Sakabe T., Tsuji Y., and Kubo T. Use of purified beta-tricalcium phosphate for filling defects after curettage of benign bone tumours. Int Orthop 30 (2006) 510-513
39. LeGeros R.Z. Properties of osteoconductive biomaterials: calcium phosphates. Clin Orthop Relat Res 395 (2002) 81-98
40. Coetzee A.S. Regeneration of bone in the presence of calcium-sulphate. Arch Otolaryngol 106 (1980) 405-409
41. Uchida A., Araki N., Shinto Y., Yoshikawa H., Kurisaka E., and Ono K. The use of calcium hydroxyapatite ceramic in bone tumour surgery. J Bone Jt Surg 72-B (1990) 298-302
42. Blaha J.D. Evolving technologies: new answers or new problems? Calcium sulphate bone void filler. Orthopedics 21 (1998) 1017-1019
43. Sidqui M., Collin P., Vitte C., and Forest N. Osteoblast adherence and resorption activity of isolated osteoclasts on calcium sulphate hemihydrate. Biometerials 16 (1995) 1327-1332
44. Boone P.S., Zimmerman M.C., Gutteling E., Lee C.K., Parsons J.R., and Langrana N. Bone attachment to hydroxyapatite coated polymers. J Biomed Mater Res 23 Suppl 2 (1989) 183-199
45. Furlong R.J., and Osborn J.F. Fixation of hip prosthesis by hydroxyapatite ceramic coatings. J Bone Jt Surg Br Vol 73-B (1991) 741-745
46. Ogose A., Hotta T., Kawashima H., Kondo N., Gu W., Kamura T., et al. Comparison of hydroxyapatite and b-tricalcium phosphate as bone substitute after excision of bone tumours. J Biomed Mater Res B Appl Biomater 72 (2005) 94-101
47. Bucholz R.W., Carlton A., and Holmes R. Interporous hydroxyapatite as a bone graft substitute in tibial plateau fractures. Clin Orthop Relat Res 240 (1989) 53-62
48. Salyer K.E., and Hall C.D. Porous hydroxyapatite as an onlay bone-graft substitute for maxillofacial surgery. Plast Reconstr Surg 84 (1989) 236-244
49. Heise U., Osborn J.F., and Duwe F. Hydroxyapatite ceramic as a bone substitute. Int Orthop 14 (1990) 329-338
50. Costantino P.D., Friedman C.D., Jones K., Chow L.C., Pelzer H.J., and Sisson G.A. Hydroxyapatite cement. I. Basic chemistry and histologic properties. Arch Otolaryngol Head Neck Surg 117 (1991) 379-384
51. Friedman C.D., Costantino P.D., Jones K., Chow L.C., Pelzer H.J., and Sisson G.A. Hydroxyapatite cement. II. Obliteration and reconstruction of the cat frontal sinus. Arch Otolaryngol Head Neck Surg 117 (1991) 385-389
52. Levani J.M., and Boisgard S. Acetabular reconstruction in total hip revision using a bone graft substitute. Clin Orthop Relat Res 330 (1996) 108-114
53. Vaccaro A.R. The role of osteoconductive scaffold in synthetic bone graft. Orthopedics 25 5 Suppl (2002) S571-S578
54. Murali S.R., Porter R.W., Gregory D.W., Marshall D., Aspden R.M., and McHardy W.J. New bone formation in an osteoporotic patient treated by intraosseus injection of bioactive materials: a case report. Cells Mater 4 (1994) 337-346
55. Shors E., and Holmes R. Bone formation in porous hydroxyapatite obtained from human biopsies. Bioceramics 6 (1993) 375-379
56. Jamshidi K., and Swain W.R. Bone marrow biopsy with unaltered architecture: a new biopsy device. J Lab Clin Med 77 (1971) 335-342
57. Campanacci M., Baldini N., Boriani S., and Sudanese A. Giant cell tumor of bone. J Bone Jt Surg Am Vol 69-A (1987) 106-114
58. Enneking W.F., Dunham W., Gebhardt M.C., Malawar M., and Pritchard D.J. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res 286 (1993) 241-246
59. Schindler O.S., Cannon S.R., Briggs T.W.R., and Blunn G.W. Stanmore custom-made extendable distal femoral replacements: clinical experience in children with primary malignant bone tumours. J Bone Jt Surg Br Vol 79-B (1997) 927-937
60. Schindler O.S., Cannon S.R., Briggs T.W.R., Blunn G.W., Grimer R.J., and Walker P.S. Use of extendable total femoral replacements in children with malignant bone tumours. Clin Orthop Relat Res 357 (1998) 157-170
61. Habal M.B., and Reddi A.H. Bone grafts and bone induction substitutes. Clin Plast Surg 21 (1994) 525-542
62. Rawlings III C.E., Wilkins R.H., Hanker J.S., Georgiade N.G., and Harrelson J.M. Evaluation in cats of a new material for cranioplasty. J Neurosurg 69 (1988) 269-275
63. Najjar T.A., Lerdrit W., and Parsons J.R. Enhanced osseointegration of hydroxyapatite implant material. Oral Surg Oral Med Oral Pathol Oral Radiol Endo 71 (1991) 9-15
64. Nilsson M., Wang J.S., Wielanek L., Tanner K.E., and Lidgren L. Biodegradation and biocompatibility of a calcium sulphate-hydroxyapatite bone substitute. J Bone Jt Surg 86-B (2004) 120-125
65. Stubbs D., Deakin M., Chapman-Sheath P., Bruce W., Debes J., Gillies R.M., and Walsh W.R. In vivo evaluation of resorbable bone graft substitutes in a rabbit tibial defect model. Biomaterials 25 (2004) 5037-5044
66. Galois L., Mainard D., and Delaguette J.P. Beta-tricalcium phosphate ceramic as a bone substitute in orthopaedic surgery. Int Orthop 26 (2002) 109-115
67. Inoue O., Ibaraki K., Shimabukuro H., and Shingaki Y. Packing with high-porosity hydroxyapatite cubes alone for the treatment of simple bone cyst. Clin Orthop Relat Res 293 (1993) 287-292
68. Urist M.R., Lange R.J., and Finerman G.A.M. Bone cell differentiation and growth factors. Science 220 (1983) 680-686
69. Mohan S., and Baylink D.J. Bone growth factors. Clin Orthop Relat Res 263 (1991) 30-47
70. Urist M.R. Bone formation by autoinduction. Science 150 (1965) 893-899
71. Urist M.R., Nielsson O., Rasmussen J., Hirota W., Lovell T., Schmalzreid T., et al. Bone regeneration under the influence of a bone morphogenic protein (BMP) beta tricalcium phosphate (TCP) composite in skull trephine defects in dogs. Clin Orthop Relat Res 214 (1987) 295-304
72. Nielsson O., and Urist M.R. Response to the rabbit metaphysis to implants of bovine bone morphogenic protein (bBMP). Clin Orthop Relat Res 195 (1985) 275-281
73. Muthukamaran N., and Reddi A.H. Bone matrix-induced local bone induction. Clin Orthop Relat Res 200 (1985) 159-164
74. Reddi A.H., Wientroub S., and Muthukumaran N. Biologic principles of bone induction. Orthop Clin North Am 18 (1987) 207-212
75. Ekelund A., Brosjo O., and Nilsson O.S. Experimental induction of heterotopic bone. Clin Orthop Relat Res 263 (1991) 102-112
76. Peltier L.F., Bickel E.Y., Lillo R., and Thein M.S. The use of plaster of Paris to fill defects in bone. Ann Surg 146 (1957) 61-69
77. MacKay D., Varlet A., and Debeaumont D. Antibiotic loaded plaster of Paris pellets: an in vitro study of a possible method in local antibiotic therapy in bone infection. Clin Orthop Relat Res 167 (1982) 263-268
78. Biesecker J.L., Marcove R.C., Huvos A.G., and Mike V. Aneurysmal bone cysts: a clinicopathologic study of 66 cases. Cancer 26 (1970) 615-625
79. Goldenberg R.R., Campbell C.J., and Bonfiglio M. Giant cell tumor of bone: an analysis of two hundred and eighteen cases. J Bone Jt Surg Am Vol 52-A (1970) 619-663
80. Sung H.W., Kuo D.P., Shu W.P., Chai Y.B., Liu C.C., and Li S.M. Giant cell tumor of bone: analysis of two hundred and eight cases in Chinese patients. J Bone Jt Surg Am Vol 64-A (1982) 755-761
81. Freiberg A.A., Loder R.T., Heidelberger K.P., and Hensinger R.N. Aneurysmal bone cysts in young children. J Paed Orthop 14 (1994) 86-91
82. Turcotte R.E., Wunder J.S., Isler M.H., Bell R.S., Schachar N., Masri B.A., Moreau G., and Davis A.M. Giant cell tumor of long bone: a Canadian Sarcoma Group study. Clin Orthop Relat Res 397 (2002) 248-258
83. Rao V.H., Bridge J.A., Neff J.R., Schaefer G.B., Buehler B.A., Vishwanatha J.K., et al. Expression of 72 kDa and 92 kDa type IV collagenase from human giant cell tumor of bone. Clin Exp Metastasis 13 (1995) 420-426